FDA.reportPublic FDA data

2 ML lidocaine hydrochloride 50 MG/ML Injection

RxCUI
1011093
RxNorm name
2 ML lidocaine hydrochloride 50 MG/ML Injection
Term type
SCD
Status
Active
Updated
2026-06-15 06:59:14

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
lidocaine hydrochloride50 MG / 1 MLlidocainelidocaine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
lidocaine6387

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STR2 ML lidocaine hydrochloride 50 MG/ML Injection1NAMES
RxNorm Name2 ML lidocaine hydrochloride 50 MG/ML Injection1NAMES
RxNorm Synonymlidocaine HCl 5 % per 2 ML Injection1NAMES
TTYSCD1ATTRIBUTES
RxCUI10110931CODES
MMSL_CODE
3 linked values
3CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 7 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00074471201rxnav_historical
00074471252rxnav_historical_indirect
00186022503rxnav_historical_indirect
00409471201rxnav_historical
00409471211rxnav_historical
00409471225rxnav_historical
00409471252rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
1f3184a9-8136-4ef1-3590-9ad15c231b265% Lidocaine Hydrochloride and 7.5% Dextrose Injection, USPHospira, Inc. | Hospira Worldwide, LLC20220125
3b0a95d8-c401-498e-a336-81ac8fdad3f3Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc. | Kwang Myung Pharm. Co., Ltd.20161102
e76bf51f-784a-4de5-b667-6fb7433ae053Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20161102
acd082d1-c167-4350-b3f2-6b8384d25140Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20150612
b3c84c93-1aa2-493f-8645-e20f4586eb30Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20150603
ebe41590-2f62-4140-92b0-2a5e03b541feSmiths Medical ASD, Inc. | Hospira, Inc.20130729
93033b8f-5f57-4b95-b556-fc0fd1ec5b87Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20130729
52370e0e-e6ba-43cd-879c-589f429452c7Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20130311
a89254e4-5905-4374-9972-3c8b2b317af9Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20130311
74d27255-d95b-4913-bc10-1201e5c805c3Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20130219
41006552-baf9-4a0d-84bc-cb9a7139911bSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20121017
7bb20ea0-ea59-414e-9cb4-2a102127b77dSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20121003
ee96df1f-5499-4679-9d7a-fed4953141f6Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120911
f5302b40-62a9-4f86-a369-abb4b418c1b0Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120809
aa30134e-8e02-4618-b44b-36eaeffd77ddSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120808
c1a66389-4006-468e-9799-07bae53de02aSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120801
4018639a-987c-43c9-9aab-fe1d09fb0e50Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120801
68bf06bd-2fe3-4da0-9c54-91c807715da4Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120731
046ae4d9-6299-42b4-affb-3dec78984c2fSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120730
51b99671-28a6-4b15-918b-85c48588fb16Smiths Medical ASD, Inc. | Hospira, Inc.20120724
034dc7c7-a093-420a-94b8-171f848cc62cNational Council for Prescription Drug Programs20120724
6a34a467-02b3-481b-8704-fd5bfcbcdc1aSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120719
1643ed50-7c75-4df9-bffb-f0353c97e3c2Smiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120620
73a7ba2e-f3d9-4b15-808c-33acdc6a70ecSmiths Medical ASD, Inc. | Hospira, Inc. | Aplicare, Inc.20120319

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine hydrochloride
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine hydrochloride
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine hydrochloride
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine hydrochloride
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009203Myocardial InfarctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine hydrochloride
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD018754Ventricular DysfunctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine hydrochloride
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine hydrochloride
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine hydrochloride
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESQUANTITY2 ML
CODESSNOMEDCT785184001
CODESVUID4005952
NAMESPrescribable Synonymlidocaine HCl 5 % in 2 ML Injection
SOURCESSourceUS Edition of SNOMED_CT